SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-110474
Filing Date
2023-10-20
Accepted
2023-10-20 16:05:45
Documents
12
Period of Report
2023-10-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2328831d1_8k.htm   iXBRL 8-K 24260
  Complete submission text file 0001104659-23-110474.txt   198699

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA hook-20231016.xsd EX-101.SCH 3030
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE hook-20231016_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hook-20231016_pre.xml EX-101.PRE 22369
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2328831d1_8k_htm.xml XML 3448
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38869 | Film No.: 231337213
SIC: 2834 Pharmaceutical Preparations